Trial Profile
A Phase 1/2 Trial of VX15/2503 in Children, Adolescents, or Young Adults With Recurrent or Relapsed Solid Tumors
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 06 Jul 2017
Price :
$35
*
At a glance
- Drugs Pepinemab (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 20 Oct 2015 According to a Vaccinex media release, this trial is expected to initiate in the first half of 2016.
- 31 Jan 2015 New trial record